Literature DB >> 22207686

Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

Rossana Maffei1, Stefania Fiorcari, Jenny Bulgarelli, Silvia Martinelli, Ilaria Castelli, Silvia Deaglio, Giulia Debbia, Marcella Fontana, Valeria Coluccio, Goretta Bonacorsi, Patrizia Zucchini, Franco Narni, Giuseppe Torelli, Mario Luppi, Roberto Marasca.   

Abstract

BACKGROUND: Chronic lymphocytic leukemia B cells display prolonged survival in vivo, but when cultured in vitro rapidly undergo spontaneous apoptosis. We hypothesize that interactions with endothelial cells in infiltrated tissues and during recirculation may have a pathogenic role in chronic lymphocytic leukemia. DESIGN AND METHODS: We evaluated apoptosis of leukemic cells after co-culture on a monolayer of human umbilical vein endothelial cells with addition of fludarabine and antibodies that block adhesion. Then, we compared microarray-based gene expression profiles between leukemic cells at baseline and after co-culture.
RESULTS: We found that the endothelial layer protected leukemic cells from apoptosis inducing a 2-fold mean decrement in apoptotic cells after 2 days of co-culture. Moreover, the endothelial layer decreased the sensitivity of chronic lymphocytic leukemia B cells to fludarabine-induced apoptosis. Physical contact with endothelium mediated by both β(1)- and β(2)- integrins is essential for the survival advantage of leukemic cells. In particular, blocking CD106 on endothelial cells or CD18 on leukemic B cells led to the almost complete abrogation of the survival advantage (>70% inhibition of viability). However, a reduction of apoptosis was also measured in leukemic cells cultured in conditioned medium collected after 2 days of co-culture, implying that survival is partially mediated by soluble factors. Overall, the contact with endothelial cells modulated 1,944 genes in chronic lymphocytic leukemia B cells, establishing a peculiar gene expression profile: up-regulation of angiogenesis-related genes, an increase of genes involved in TGFβ and Wnt signaling pathways, secretion of cytokines recruiting stromal cells and macrophages and up-regulation of anti-apoptotic molecules such as Bcl2 and Survivin.
CONCLUSIONS: Our study supports the notion that endothelial cells are major players in the chronic lymphocytic leukemia microenvironment. Adhesion to endothelium strongly supports survival, protects from drug-induced apoptosis and extensively modifies the gene expression profile of leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207686      PMCID: PMC3366665          DOI: 10.3324/haematol.2011.054924

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  40 in total

1.  CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression.

Authors:  D McCabe; L Bacon; K O'Regan; C Condron; J R O'Donnell; P T Murphy
Journal:  Leukemia       Date:  2004-03       Impact factor: 11.528

2.  Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.

Authors:  D J McConkey; M Aguilar-Santelises; P Hartzell; I Eriksson; H Mellstedt; S Orrenius; M Jondal
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

3.  Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro.

Authors:  R J Collins; L A Verschuer; B V Harmon; R L Prentice; J H Pope; J F Kerr
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

4.  Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study.

Authors:  C Schmid; P G Isaacson
Journal:  Histopathology       Date:  1994-05       Impact factor: 5.087

5.  Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.

Authors:  Stefano Molica; Angelo Vacca; Domenico Ribatti; Antonio Cuneo; Francesco Cavazzini; Domenico Levato; Gaetano Vitelli; Luigi Tucci; Aldo M Roccaro; Franco Dammacco
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy.

Authors:  Sergio Dias; Margaret Choy; Kari Alitalo; Shahin Rafii
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

7.  Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas.

Authors:  Livio Trentin; Anna Cabrelle; Monica Facco; Davide Carollo; Marta Miorin; Alicia Tosoni; Paola Pizzo; Gianni Binotto; Linda Nicolardi; Renato Zambello; Fausto Adami; Carlo Agostini; Gianpietro Semenzato
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

8.  Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.

Authors:  Barbara Margosio; Daniela Marchetti; Veronica Vergani; Raffaella Giavazzi; Marco Rusnati; Marco Presta; Giulia Taraboletti
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

9.  Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells.

Authors:  J Edelmann; L Klein-Hitpass; A Carpinteiro; A Führer; L Sellmann; S Stilgenbauer; U Dührsen; J Dürig
Journal:  Leuk Res       Date:  2008-04-14       Impact factor: 3.156

Review 10.  The endothelin axis: emerging role in cancer.

Authors:  Joel Nelson; Anna Bagnato; Bruno Battistini; Perry Nisen
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

View more
  15 in total

1.  Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.

Authors:  Stefania Fiorcari; Silvia Martinelli; Jenny Bulgarelli; Valentina Audrito; Patrizia Zucchini; Elisabetta Colaci; Leonardo Potenza; Franco Narni; Mario Luppi; Silvia Deaglio; Roberto Marasca; Rossana Maffei
Journal:  Haematologica       Date:  2014-11-14       Impact factor: 9.941

2.  FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.

Authors:  Preetesh Jain; Hun Ju Lee; Wei Qiao; William Wierda; Ohad Benjamini; Jan Burger; Alessandra Ferrajoli; Zeev Estrov; Hagop Kantarjian; Michael Keating; Susan O'Brien
Journal:  Cancer       Date:  2014-07-15       Impact factor: 6.860

Review 3.  Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.

Authors:  Elisa Ten Hacken; Jan A Burger
Journal:  Biochim Biophys Acta       Date:  2015-07-17

4.  The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Authors:  Rossana Maffei; Jenny Bulgarelli; Stefania Fiorcari; Linda Bertoncelli; Silvia Martinelli; Carla Guarnotta; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Sara De Biasi; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Claudio Tripodo; Mario Luppi; Andrea Cossarizza; Roberto Marasca
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

Review 5.  Bone marrow niches in haematological malignancies.

Authors:  Simón Méndez-Ferrer; Dominique Bonnet; David P Steensma; Robert P Hasserjian; Irene M Ghobrial; John G Gribben; Michael Andreeff; Daniela S Krause
Journal:  Nat Rev Cancer       Date:  2020-02-28       Impact factor: 60.716

6.  ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.

Authors:  Sarah Weiler; Jolaolu A Ademokun; John D Norton
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

7.  Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor.

Authors:  Rossana Maffei; Jenny Bulgarelli; Stefania Fiorcari; Silvia Martinelli; Ilaria Castelli; Vanessa Valenti; Davide Rossi; Goretta Bonacorsi; Patrizia Zucchini; Leonardo Potenza; Daniele Vallisa; Valter Gattei; Giovanni Del Poeta; Francesco Forconi; Gianluca Gaidano; Franco Narni; Mario Luppi; Roberto Marasca
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

8.  Extracellular Histone Released from Leukemic Cells Increases Their Adhesion to Endothelium and Protects them from Spontaneous and Chemotherapy-Induced Leukemic Cell Death.

Authors:  Hyun Ju Yoo; Jee-Soo Lee; Ji-Eun Kim; JaYoon Gu; Youngil Koh; Inho Kim; Hyun Kyung Kim
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

9.  Real-time monitoring of hematopoietic cell interaction with fibronectin fragment: the effect of histone deacetylase inhibitors.

Authors:  Adam Obr; Pavla Röselová; Dana Grebeňová; Kateřina Kuželová
Journal:  Cell Adh Migr       Date:  2013-04-08       Impact factor: 3.405

10.  Identification of a novel luminal molecular subtype of breast cancer.

Authors:  Anna Dvorkin-Gheva; John A Hassell
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.